title: Kyoto University experience with intraoperative radiation therapy.
abstract: To date, intraoperative radiotherapy has been performed at Kyoto University Hospital in a total of 480 patients with malignancies various sites. Among these, patients with disease of 4 major sites were selected for prognostic analysis. For gastric cancer patients survival was improved by the adjuvant intraoperative radiotherapy compared with gastrectomy alone in those with advanced nodal or serosal involvement [P < 0.05 for n2 + n3' 0.1 > P > 0.05 for s(+)]. Also, the survival for the adjuvant radiotherapy group was significantly improved in patients with stage II-III pancreatic cancer who underwent non-curative resection (P < 0.001). For patients with soft tissue sarcomas of the extremities, intraoperative radiotherapy was performed after the tumours were surgically removed to the greatest e* possible. Operation curability had a great impact on the local tumour control rate (82% for curative resection versus 18% for non-curati resection) and on the long-term survival rates (65% versus 8%, respectively). In patients with osteosarcoma, a large single do* 50-55 Gy was applied to the affected limb in an attempt to achieve local control and limb salvage. By this method, good local control attained, and a 10-year survival rate showed improvement following the introduction of cisplatinum into intensive chemotherapy.
authors.affiliation: Department of Oncology, Kyoto University.
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Shibamoto
authors.forename: K
authors.initials: K
authors.lastname: Sasai
authors.forename: Y
authors.initials: Y
authors.lastname: Nishimura
authors.forename: M
authors.initials: M
authors.lastname: Abe
mesh_terms: D001859:Bone Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D005121:Extremities / Q000473:pathology / Q000528:radiation effects / Q000601:surgery; D006785:Hospitals, University; D006801:Humans; D007430:Intraoperative Care; D007564:Japan; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009369:Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D012516:Osteosarcoma / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012509:Sarcoma / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D012704:Serous Membrane / Q000473:pathology / Q000528:radiation effects; D013274:Stomach Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D015996:Survival Rate
chemical_list: D002945:Cisplatin